154 related articles for article (PubMed ID: 12435524)
21. Arachidonate transforming and immunomodulating agents: unapproved uses or indications.
Lotti TM; Menchini G; Spallanzani A; Moretti S; Ghersetich I; Bianchi B
Clin Dermatol; 2000; 18(1):119-23. PubMed ID: 10701093
[No Abstract] [Full Text] [Related]
22. Hormones: androgens, antiandrogens, anabolic steroids, estrogens--unapproved uses or indications.
Güneş AT; Fetil E
Clin Dermatol; 2000; 18(1):55-61. PubMed ID: 10701086
[No Abstract] [Full Text] [Related]
23. Vitamins A, B, C, D, E, F, trace elements and heavy metals: unapproved uses or indications.
Nicolaidou E; Katsambas AD
Clin Dermatol; 2000; 18(1):87-94. PubMed ID: 10701089
[No Abstract] [Full Text] [Related]
24. Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen.
Paquette D; Rothe MJ
Clin Dermatol; 2000; 18(1):103-11. PubMed ID: 10701091
[No Abstract] [Full Text] [Related]
25. Lefunomide in combination therapy.
Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC
J Rheumatol Suppl; 2004 Jun; 71():25-30. PubMed ID: 15170905
[TBL] [Abstract][Full Text] [Related]
26. Phototherapy, photochemotherapy, and photodynamic therapy: unapproved uses or indications.
Ledo E; Ledo A
Clin Dermatol; 2000; 18(1):77-86. PubMed ID: 10701088
[No Abstract] [Full Text] [Related]
27. Pentoxifylline as a treatment for granuloma annulare.
Wong GN; Wee E; Tam M; Kelly R
Australas J Dermatol; 2019 Nov; 60(4):328-331. PubMed ID: 31115037
[No Abstract] [Full Text] [Related]
28. Low-dose sulfasalazine in a case of pyodermatitis-pyostomatitis vegetans.
Li S; Li Z; Feng S
J Am Acad Dermatol; 2020 May; 82(5):e149-e150. PubMed ID: 30352281
[No Abstract] [Full Text] [Related]
29. Treatment of persistent alopecia areata with sulfasalazine.
Rashidi T; Mahd AA
Int J Dermatol; 2008 Aug; 47(8):850-2. PubMed ID: 18717871
[TBL] [Abstract][Full Text] [Related]
30. Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis.
Skosey JL
J Rheumatol Suppl; 1988 Sep; 16():5-8. PubMed ID: 2903927
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy in early rheumatoid arthritis.
Gossec L; Dougados M
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S174-8. PubMed ID: 14969072
[TBL] [Abstract][Full Text] [Related]
32. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
[No Abstract] [Full Text] [Related]
33. Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative.
el-Mofty M; el-Darouti M; Rasheed H; Bassiouny DA; Abdel-Halim M; Zaki NS; el-Hanafy G; el-Hadidi H; Azzam O; el-Ramly A; Fawzy M
J Dermatolog Treat; 2011 Feb; 22(1):31-7. PubMed ID: 20073999
[TBL] [Abstract][Full Text] [Related]
34. Oral pentoxifylline vs topical betamethasone in Schamberg disease: a comparative randomized investigator-blinded parallel-group trial.
Panda S; Malakar S; Lahiri K
Arch Dermatol; 2004 Apr; 140(4):491-3. PubMed ID: 15096387
[No Abstract] [Full Text] [Related]
35. Treatments for Cutaneous Lichen Planus: A Systematic Review and Meta-Analysis.
Atzmony L; Reiter O; Hodak E; Gdalevich M; Mimouni D
Am J Clin Dermatol; 2016 Feb; 17(1):11-22. PubMed ID: 26507510
[TBL] [Abstract][Full Text] [Related]
36. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Tolia V
Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
[TBL] [Abstract][Full Text] [Related]
37. Evaluating lipid-lowering trials in the twenty-first century.
Roberts WC
Am J Cardiol; 2009 May; 103(9):1325-8. PubMed ID: 19406281
[No Abstract] [Full Text] [Related]
38. Miscellaneous treatments: thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine.
Sanchez MR
Clin Dermatol; 2000; 18(1):131-45. PubMed ID: 10701095
[No Abstract] [Full Text] [Related]
39. The state of the art in the management of inflammatory bowel disease.
Hanauer SB; Present DH
Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
[TBL] [Abstract][Full Text] [Related]
40. Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies.
Ambrus JL; Anain JM; Anain SM; Anain PM; Anain JM; Stadler S; Mitchell P; Brobst JA; Cobert BL; Savitsky JP
Clin Pharmacol Ther; 1990 Jul; 48(1):50-6. PubMed ID: 2196145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
